Published

A single psilocybin dose is associated with long-term increased mindfulness, preceded by a proportional change in neocortical 5-HT2A receptor binding

No abstract is available for this record.

Open source BibTeX RIS

Bibliographic context

Journal: European Neuropsychopharmacology
Date: 2020-03-03
Source: OpenAlex
DOI: 10.1016/j.euroneuro.2020.02.001
PubMed: 32146028

Authors

M. Madsen Patrick M. Fisher Dea Siggaard Stenbæk Sara Kristiansen Daniel Burmester Szabolcs Lehel Tomáš Páleníček Martin Kuchař Claus Svarer Brice Ozenne Gitte M. Knudsen

Watch author

Topics and keywords

psilocybin Receptor Pharmacology Other Psilocybin Mindfulness Psychology Clinical psychology Medicine Internal medicine Hallucinogen Psychiatry Psychedelics and Drug Studies Chemical synthesis and alkaloids Neurotransmitter Receptor Influence on Behavior

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

A single psilocybin dose is associated with long-term increased mindfulness, preceded by a proportional change in neocortical 5-HT2A receptor binding2020-03-03

Related papers

Psilocybin-assisted psychotherapy for methamphetamine dependence: a case report involving daily methamphetamine useFrontiers in Psychiatry · 2024-12-05 PTSD Treatment: An Inquiry into the Promising Potential of PsilocybinJournal of Advances in Medicine and Medical Research · 2024-07-23 Psilocybin-assisted psychotherapy as a rapid-acting treatment for cancer-related depression and anxiety: Evidence from a network meta-analysisThe International Journal of Psychiatry in Medicine · 2025-04-24 Psilocybin-Assisted Therapy for Brain Cancer Related Existential Distress: A Case-ReportJournal of Palliative Medicine · 2024-09-11 Preadministration of Lorazepam Negates the Long-Term Antidepressant-Like Effects of Psilocybin in Male Wistar Kyoto RatsPsychedelic Medicine · 2025-12-15 Advancing treatment paradigms: the role of psilocybin in managing major depressive disorderAnnals of Medicine and Surgery · 2025-11-23 Use of Psilocybin in the Treatment of Mental Disorders: Systematic Review of Clinal TrialsJournal of Complementary Medicine & Alternative Healthcare · 2024-09-16 Assessing expectancy and suggestibility in a trial of escitalopram v. psilocybin for depressionPsychological Medicine · 2024-01-21